Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenue $ 36
Cost of revenue 54  
Gross loss (18)
Operating expenses:    
Research and development 6,048 4,262
Sales and marketing 4,312 2,415
General and administrative 8,547 6,287
Total operating expenses 18,907 12,964
Operating loss (18,925) (12,964)
Warrant expense (3,156)
Loss on change in estimated fair value of contingent royalty obligation (291) (252)
Finance income (expense), net 103 (6)
Other income 38
Foreign currency (loss) gain (26) 22
Loss before income taxes (22,257) (13,200)
Income tax expense
Net loss $ (22,257) $ (13,200)
Basic and diluted loss per common share (in dollars per share) $ (1.47) $ (1.28)
Weighted average number of common shares outstanding, basic and diluted (in shares) 15,137,144 10,332,554